A phase II trial of a chemotherapy-free combination of ponatinib and blinatumomab in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
暂无分享,去创建一个
H. Kantarjian | T. Kadia | F. Ravandi | E. Jabbour | N. Daver | N. Jain | N. Short | C. Loiselle | K. Sasaki | K. Chien | M. Kwari | M. Konopleva | G. Bravo | W. Macaron | R. Delumpa | J. Thankachan | E. Mayor | Wu Deen | Rebecca E. Garris | Yesid Alvarado Valero